What Basophil Testing Tells Us About CSU Patients – Results of the CORSA Study
Basophil testing is the most effective single approach for diagnosing type-IIb autoimmune chronic spontaneous urticaria (TIIbaiCSU). A positive basophil test has been linked to long disease duration, higher disease activity, a poor response to antihistamines and omalizumab, and a better response to...
Main Authors: | João Marcelino, Katrine Baumann, Per Stahl Skov, Maria Conceição Pereira Santos, Inga Wyroslak, Jörg Scheffel, Sabine Altrichter, Anders Woetmann, Manuel Pereira-Barbosa, Célia Costa, Marcus Maurer |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.742470/full |
Similar Items
-
Basophil Activation in Immediate Drug Hypersensitivity Reactions and Basophil Activation Test (BAT)
by: Öner Özdemir
Published: (2017-09-01) -
Basophil Activation Test to Optimize the Diagnosis of Adverse Effects Following Immunization to Vaccines
by: Salvatore Chirumbolo
Published: (2013-09-01) -
Lower IgA Levels in Chronic Spontaneous Urticaria Are Associated With Lower IgE Levels and Autoimmunity
by: Merle Sauer, et al.
Published: (2021-05-01) -
Life-threatening rocuronium-induced anaphylactic shock without cutaneous manifestations successfully reversed with sugammadex: a case report
by: Yoshiaki Takise, et al.
Published: (2020-12-01) -
Serum induced CD63 and CD203c activation tests in chronic urticaria
by: Chomiciene Anzelika, et al.
Published: (2014-04-01)